Wave Life Sciences to Present at Stifel 2022 CNS Days

2 years ago

CAMBRIDGE, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed…

Latest Research Evaluating VASCEPA® (Icosapent Ethyl) to be Presented at the American College of Cardiology’s 71st Annual Scientific Session

2 years ago

Amarin-Supported Research and Analyses to Be Featured in Six PresentationsDUBLIN, Ireland and BRIDGEWATER, N.J., March 21, 2022 (GLOBE NEWSWIRE) --…

Red Light Holland Successfully Imports Psilocybin iMicrodose Packs into St. Vincent and the Grenadines Under a First-Ever Authorized Import Approval Process by the Country’s Bureau of Standards and the Ministry of Health

2 years ago

Red Light Holland's licensed subsidiary Scarlette Lillie Sciences and Innovation granted authorization for first ever psilocybin import into St. Vincent…

CENTR’s Explosive Retail Growth Continues in 2022

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - March 21, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),…

Canadian Psychedelic Research Company Lophos Pharmaceuticals Inc. Engages KGK Science for Novel Peyote Study

2 years ago

Toronto, Ontario--(Newsfile Corp. - March 21, 2022) - Lophos Pharmaceuticals Inc., a Canadian psychedelic research company focused on cultivation and…

AI voice-driven speech recognition suite, Augnito, enhances radiology and clinical reporting for Wellbeing Software

2 years ago

Bespoke speech recognition technology, Augnito, aids Wellbeing Software with highly accurate Radiology Information System workflows. Scribetech has announced the integration…

AlzeCure Presents New Preclinical Alzstatin Data at Alzheimer Conference

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / March 21, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical…

15 Dosell are Implemented in a New Municipality

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / March 21, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that the partner Zafe…

IRLAB Nominates New Candidate Drug, IRL757, to Treat Apathy in Neurological Disorders

2 years ago

GOTHENBURG, SWEDEN / ACCESSWIRE / March 21, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A) takes important steps…

Evotec Receives € 3 m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme

2 years ago

FIRST DOSING OF A STUDY PARTICIPANT TRIGGERS MILESTONE PAYMENT OF € 3 M TO EVOTECPHASE II CLINICAL TRIAL INITIATED BY…